EUTM file information
019078889
JEMFRAXTA
September 11, 2024
Trademark Summary
The trademark application JEMFRAXTA was filed by Larimar Therapeutics, Inc., a U.S. corporation (the "Applicant"). Application under examination.
The application was filed in English (German was selected as the second language).
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Pharmaceutical preparations for the treatment of mitochondrial disorders
- Pharmaceutical preparations and substances for treatment of genetic diseases
- Pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria
- Pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders
- Pharmaceuticals that treat genetic diseases by use of carrier proteins
- Pharmaceutical preparations for the treatment of ataxia
- Pharmaceutical preparations for the treatment of Friedreich's Ataxia
- Pharmaceutical preparations for protein replacement therapy
- Pharmaceutical preparations for frataxin replacement therapy.